Literature DB >> 21780524

Radiofrequency-assisted liver resection: higher incidence of infectious complications?

Z Subrt1, A Ferko, B Jon, F Cecka.   

Abstract

AIM: To evaluate clinical experience with radiofrequency (RF)-assisted liver resection in non-cirrhotic and non-cholestatic patients with metastatic liver disease.
METHODS: A group of consecutive patients who underwent RF-assisted liver resection for metastatic liver disease was prospectively followed.
RESULTS: Between July 2005 and April 2008, 95 liver RF-assisted liver resections were performed, 71 of them for metastatic liver disease. The mean hospital stay was 14 (range 5-40) days. The mean operation time was 141 (range 64-233) minutes. The mean duration of RF coagulation was 10 (range 9-12) minutes. A total of 37 complications in 24 (33%) patients were recorded, including 12 (16.9%) infected collections in resection line that had to be drained percutaneously. The 30-day postoperative mortality was zero.
CONCLUSION: This study indicates that RF-assisted resection may have a benefit in decreasing peroperative blood loss and the number of blood transfusions. Nevertheless, an increased incidence of infectious complications and pleural effusions that required evacuation was noted.

Entities:  

Mesh:

Year:  2011        PMID: 21780524     DOI: 10.1080/00015458.2011.11680729

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  2 in total

1.  Radiofrequency-assisted versus clamp-crushing parenchyma transection in cirrhotic patients with hepatocellular carcinoma: a randomized clinical trial.

Authors:  Min Li; Wei Zhang; Yi Li; Peizhi Li; Jinzheng Li; Jianping Gong; Yongjun Chen
Journal:  Dig Dis Sci       Date:  2012-09-25       Impact factor: 3.199

2.  Liver Parenchymal Transection Through Radiofrequency Ablation Using a Radial Probe: Technical Report of a New Modality.

Authors:  Venu Bhargava Mulpuri; Prasanth Gurijala; Bhaskar R Yerolla; Gokul Kumar; Ashwini Dutt
Journal:  Cureus       Date:  2021-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.